Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jucker

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Nature Neuroscience|November 17, 2020
Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in lifeRuth E Uhlmann, Christine Rother, Jay Rasmussen, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 2020
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and UnknownsDavid M Asher, Ermias Belay, Eileen Bigio, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Nature|November 17, 2022
Medin co-aggregates with vascular amyloid-β in Alzheimer's diseaseJessica Wagner, Karoline Degenhardt, Marleen Veit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Nature Neuroscience|November 17, 2020
Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in lifeRuth E Uhlmann, Christine Rother, Jay Rasmussen, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 2020
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and UnknownsDavid M Asher, Ermias Belay, Eileen Bigio, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Nature|November 17, 2022
Medin co-aggregates with vascular amyloid-β in Alzheimer's diseaseJessica Wagner, Karoline Degenhardt, Marleen Veit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Pageof 21